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This work is to study the baicalin and its three analogs, baicalin, wogonoside, and wogonin, on the protective eﬀe cto fn e u r o nf r o m
oxygen-glucose deprivation (OGD) and toll-like receptor 2 (TLR2) expression in OGD damage. The results showed that baicalin
and its three analogs did protect neurons from OGD damage and downregulated protein level of TLR2. D-Glucopyranosiduronic
acid on site 7 in the structure played a core of cytotoxicity of these ﬂavonoid analogs. The methoxyl group on carbon 8 of the
structure had the relation with TLR2 protein expression, as well as the anti-inﬂammation. In addition, we detected caspase3 and
antioxidation capability, to investigate the eﬀect of four analogs on cell apoptosis and total antioxidation competence in OGD
model.
1.Introduction
Scutellariae radix, a Chinese medicine, has various phar-
macological eﬀects such as antibacterial, antivirus, anti-
inﬂammation, antioxidation, and antistroke in clinic [1–
4]. Its active ingredient is a kind of ﬂavones, consisting
of baicalin, baicalein, wogonin, and wogoniside brieﬂy
(Figure 1)[ 5]. It is reported that Scutellariae radix protects
neurons from the injury of ischemia and reperfusion [6].
Baicalin, the major component of the ﬂavones, was con-
ﬁrmed with the neuroprotection of the damage by ischemia
and reperfusion and the action on central nerve system
[7–10]. Recently, baicalein was studied with a promising
eﬀect of neuroaction on multiple sites [11–17]. However, no
report presented the eﬀect of baicalin and TLR2 expression
on neurons. A few researches reported that wogonin and
wogonoside acted on the neurons [18–20]. Baicalin and
baicalein were studied as an antioxidant; in a few models
baicalein was even stronger than baicalin in reducing several
freeredials[21].Comparingthem,baicaleinandbaicalinsig-
niﬁcantly attenuated the cellular injury induced by hydrogen
peroxide, but wogonin and wogonoside acted more weakly
[22]. It is suggested that there must be other mechanisms of
wogonin and wogonoside on neuroprotection.
As the anti-inﬂammation of baicalin and baicalein was
conﬁrmed, the researches on the innate immune response
were studied in cerebral ischemia reperfusion and presented
the reason partly why the anti-inﬂammation of baicalin and
baicalein was one of the major assays for the protection
of brain from the ischemia reperfusion damage [23–27].
Severalreceptorswereindicatedasthekeytargetsofischemic
reperfusion injury in the glia, such as toll like receptors
(TLRs) and the NODs (nucleotide-binding oligomerisation
domain) [28–30]. Our prior experiment showed baicalin
attenuated the expression of NOD2 and TNFα in neurons
with the ischemia and reperfusion damage in vivo and2 Journal of Biomedicine and Biotechnology
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Figure 1: Chemical structures of baicalin and its natural analogs,
baicalein, wogonoside, and wogonin.
in vitro [31]. Wogonoside was reported with inhibition of
lipopolysaccharide-induced angiogenesis via toll-like recep-
tor 4 (TLR4) signal transduction [32]. However, TLR2 has
not been investigated by baicalin and its natural analogs.
Based on the previously mentioned information, we
investigated the regulation behavior of baicalin and its
analogs through one kind of neuron cell PC12 in order to
explore the possible targets of baicalin and its analogs in
innate immune reactions during the oxygen and glucose
deprivation (OGD) and the relations between the chemical
structure and the eﬀect among baicalin and its natural
analogs. Since TLR2 is one of the initial receptors in innate
immunity and the inﬂammatory activation, as well as TNFα,
can be inhibited by baicalin in lung cells [33, 34], the protein
expression of TLR2 and TNFα were tested to ﬁnd out the
role of baicalin and its analogs in this nerve injury models.
Meanwhile, caspase3 is a well-known index of apoptosis, and
several studies reported that a few ﬂavones could induce
apoptosis of inﬂammatory cells [35–37], so we detected the
expression of caspase3 protein. Additionally, the eﬀect of the
four analogs on the total antioxidation capability of cells in
OGD model was also detected in this paper, which further
compared the whole competence of these ﬂavones [38].
2.MaterialsandMethods
2.1. Chemicals and Materials. Baicalin (purity was 98%) was
presentedbyDr.LujunZhang,LaboratoryofPharmaceutical
Sciences,TsinghuaUniversity.Wogonoside(puritywas98%)
was presented by Dr. Xiuwei Yang, School of Pharmaceutical
Science, Peking university. Baicalein and wogonin, all with
purity of 98% (batch number 111595-200604 and 111514-
200403), were purchased from China National Institute
for the Control of Pharmaceutical and Biological Products.
Deionised water was used throughout the experiment. Other
organic solvents and reagents were of analytical-reagent
grade.PBSbuﬀerwithpH7.4waspreparedinourlaboratory.
PC12 cells were provided by the Cell Bank of the Institute
of Fundamental Medicine, Chinese Academy of Medical
Science (Beijing, China). Fetal bovine serum (FBS) and
RPMI 1640 medium was purchased from GIBCO. Anti-
TLR2/TNFα/caspase3/β-actin antibodies were purchased
from Santa Cruz Company (USA). The secondary antibody
was purchased from Zhongshan Company (Beijing, China).
TheTotalantioxidationcapability(T-AOC)detectionkitwas
purchased from Nanjing Jiancheng Bioengineering Institute
(Nanjing, China).
2.2. Cell Culture. PC12 cells were adjusted to about 1 ×
106 cells/mL with 2mL inoculate into each well of 6-well
plates (Costar) in RPMI 1640 supplemented with 10%
fetal bovine serum (FBS) and 5% horse serum and peni-
cillin/streptomycin(100U/mLeach).Cellswereculturedina
humidiﬁed incubator (5% CO2) (Sanyo, Japan) at 37◦Ca n d
allowed to attached for at least 48h.
2.3. Cytotoxicity Assays In Vitro. The safe dosages of baicalin
and its three analogs to the cells were evaluated by MTT
(methylthiazol tetrazolium) assay in vitro.A f t e r2 4ho fc e l l s
incubation in 96-well plates, baicalin and its analogs were
added with the dosage from 10mg/mL to 0.001mg/mL.
24h later of the compounds added, culture medium in 96-
well plates were incubated with MTT (5mg/mL, 200μL
per well) at 37◦C for 4h. Then the medium was carefully
aspirated, and 200μL dimethylsulfoxide (DMSO) per well
was added to dissolve the blue formazan products. The
values of absorbance at 490nm were measured using a
microplate reader (Model 550Bio-RadUSA). The results of
the absorbance of the test wells were expressed as cell alive.
The 50% cytotoxicity concentration (CC50) was calculated
[39].
2.4. Cells for Oxygen-Glucose Deprivation. For the oxygen-
glucosedeprivation(OGD)[40],wereplacedthegrowthme-
dium with glucose-free culture medium (2mL per well)
and put the plates into an incubator (YCP-30Q, Changsha,
China) full of 95% N2/5% CO2 at 37◦C for 120min. Then
cells were returned to the normal feeding medium and
incubated under normal conditions at 37◦C (Sanyo, Japan)
for the speciﬁc time for later experiments. Control cell
cultures not deprived of oxygen and glucose were incubated
under normal conditions in the medium with glucose.
For protective eﬀect of the compounds from OGD
damage, the cell living assay was carried out as previously
described. After 24h of cells incubation in 96-well plates,
baicalin and its analogs were added with the dosages from
10mg/mL to 0.001mg/mL. 24h later from adding the
compounds, culture medium in 96-well plates was incubated
with MTT (5mg/mL, 200μLp e rw e l l )a t3 7 ◦Cf o r4 h .
The medium was carefully aspirated, and 200μLD M S O
per well was added to dissolve the blue formazan products.
The values of absorbance at 490nm were measured using
a microplate reader. The results of the absorbance of theJournal of Biomedicine and Biotechnology 3
test wells were expressed as cell alive. The 50% eﬀective
concentration (EC50) was calculated [39]. Combined with
cytotoxicity (CC50) of the compounds, the safety indices
(SIs) were calculated by EC50/CC50 [41].
ForTLR2/TNFαandcaspase3study,theminimumsafety
concentration of baicalin and its analogs was ordered as
10μg/mL. These compounds (10μg/mL) were added when
culture medium was exchanged with glucose solution and
cells were cultured in normal condition. The cells were
picked up for protein experiment at the speciﬁc reperfusion
time (0.5, 1, 3, 6h) after baicalin and its analogs added. In
control, medium was used as a vehicle and the cells were
picked up at the reperfusion time of 6h.
2.5. Preparation of Samples. Two groups without medicines
were employed as control. One group of the cells was seeded
in the medium with normal growth medium during all the
experimental process without oxygen-glucose deprivation.
The second group was seeded in the medium with process
of oxygen-glucose deprivation as the model control. At each
timepoint,thecellsamplewaspreparedthesameasprevious
description. The medium was drawn out from each well, and
cells were washed three times with cold PBS (pH 7.4) and
used with 100μL RIPA to gather total protein for Western
blotting.
2.6. Western Blot. Western blot assay for protein expression
ofβ-actin,TLR2,TNFα,andCaspase3wasreferencedin[42]
withminimodiﬁcationasfollows:loadedsamplesintothegel
(10%), was run until the marker (purchased from Fermentas
Republic of Lithuania) and went to the end of the gel. The
transfershouldbesemidryfor60minat12voltsand280mA.
Then the membrane was blocked with 10% milk in PBST
(1 × PBS + 0.1% Tween20) for 60min shaking slowly at
room temperature. The membrane was put in 1mL PBST
with antibody in a 1:1000 dilution, incubated for 60min at
room temperature on the shaker, and washed for 3 times
using PBST after the primary antibody incubation. After
that, the membrane was incubated for 60min in PBST with
the secondary antibody with the concentration 1:3000. The
membrane was washed 3 times with PBST at last.
2.7. Total Antioxidation Capability Detection. The principle
of this experiment was to detect the color change following
the reduction of Fe3+ to Fe2+ by the reducing components
in the samples. The reducing components might include
the enzyme and nonenzymatic molecules such as lipid-
solubleantioxidantvitaminEandwater-solubleantioxidants
vitamin C, bilirubin, and uric acid. Then the optical density
was measured at 520nm with a microplate reader [43]. The
cell sample was prepared the same as previous description
andpickedatthespeciﬁcreperfusiontime(6h)afterbaicalin
and its analogs added. The medium was drawn out from
each well, and the cells were washed three times with cold
PBS (pH 7.4). These cells in the plate were resolved with
PBS (1mL/well) by repeated freezing and thawing. The
supernatant was collected for T-AOC test after centrifuge
12 000rpm/min.
2.8. Data Analysis. A l lv a l u e sw e r ee x p r e s s e da sm e a n± S.D.
Data were statistically analyzed by ANOVA. The Newman-
Keuls comparisons were used to determine the source of
signiﬁcant diﬀerences where appropriate. P values below
0.05 were considered statistically signiﬁcant. The software
of CALC 2.0 (The China Association of Pharmacology) was
employed for CC50 and EC50 calculation.
3. Results
3.1. Cell Growing Proﬁle. The cells were seeded in the plates
of the medium with 10% FBS for 48h. They would not be
used for the experiments till they grew well and attached to
each other tightly in the ﬂat of multiwell plates.
3.2. MTT Tests of Cytotoxicity. I no r d e rt oe x a m i n et h e
cytotoxicity and determine the safe dosages of baicalin and
its analogs, MTT assay was conducted on PC12 cells in
vitro. Based on the experiments, 10μg/mL of baicalin and
wogonoside was the highest in safety concentration on
normal PC12 cells, and 1μg/mL of baicalein and wogonin
was the highest in safety concentration on normal PC12 cells
(Figure 2).
In PC12 cells treated with oxygen-glucose deprivation,
only less than 40% cells survived with comparison of normal
control (P<0.05). Compared with model control, the
minimum eﬀective concentration (MEC) of baicalin and
wogonin was 10μg/mL, while the MEC of both wogonoside
and baicalein was the same at 1μg/mL. The maximum
eﬀective concentration (MAXEC) of baicalin and woronin
was the same at 1mg/mL, implying the same safety of them.
The MAXEC of wogonoside was 1mg/mL, but the MAXEC
of baicalein was only at 10μg/mL. It was suggested that
baicalein was more cytotoxic than that of wogonoside. All
these compounds were not shown in the concentration-
dependent manner distinctly (Figure 3).
The CC50 of baicalin (188.4μg/mL or 0.422mmol/L)
showed large diﬀerences from other three compounds.
Baicalein showed more cellular toxicity with CC50 8.9μg/mL
(equal to 0.0329mmol/L). Wogonin and wogonoside dis-
played toxicity similar to CC50 10.6μg/mL (equal to
0.0373mmol/L) and 13.7μg/mL (equal to 0.0298mmol/L),
respectively. However, baicalein was more eﬀective of
protection of the cells from OGD damage. The mini-
mum eﬀective dosage of baicalein was 1μg/mL (equal to
0.0037mmol/L). The EC50 of baicalin was 1.2μg/mL (equal
to 0.0027mmol/L), and the EC50 of Wogonin and wogono-
side was 4.3μg/mL (equal to 0.0151mmol/L) and 7.4μg/mL
(equal to 0.0161mmol/L). Comparing between the toxicity
and the eﬀect, the safety indices of the four compounds were
156 (baicalin), 8.89 (baicalein), 2.47 (wogonin), and 1.85
(wogonoside), respectively (Table 1).
3.3. Eﬀect on the Expressions of TLR2, TNFα, and Caspase3.
Injured by OGD, the proteins of TLR2 and TNFα in the
cells were expressed distinctly which means the OGD stim-
ulated the innate immune reaction, causing inﬂammation.
The caspase3 protein in OGD model was upregulated in4 Journal of Biomedicine and Biotechnology
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Figure 2: Cytotoxcity of baicalin, wogonoside, baicalein, and wogonin in normal PC12 cells (MTT assay). After 24h of cells incubation
in 96-well plates, the chemicals were added with the dosage from 10mg/mL to 0.001mg/mL. ∗P<0.05 versus normal control. Data were
presented as mean ± S.D. from seven independent experiments.
Table 1: Values of CC50 and EC50 of baicalin, baicalein, wogono-
side, and wogonin.
Compounds CC50 EC50 SI
μg/mL (mmol/L) μg/mL (mmol/L)
Baicalin 188.4 (0.422) 1.2 (0.0027) 156
Wogonoside 13.7 (0.0298) 7.4 (0.0161) 1.85
Baicalein 8.9 (0.0329) 1.0 (0.0037) 8.89
Wogonin 10.6 (0.0373) 4.3 (0.0151) 2.47
CC50 means the 50% cytotoxic concentration.
EC50 means the 50% eﬀective concentration.
SI (the safety index) was calculated by CC50/EC50.
some degree, but there was no signiﬁcant statistical value
(Figure 4). Baicalin attenuated the protein expression of
TLR2 and TNFα 3 hours after the administration. When
baicalin took eﬀect for 0.5h, the expression of TLR2 showed
statistical signiﬁcance no matter when compared with the
normal or comparing with the model (P<0.05), and
the TLR2 expression of 1h increased (comparing with the
normal, P<0.05); however, its expression of 3h or 6h
showed no obvious diﬀerence comparing with the normal
(comparing with the model, P<0.05). The expression of
TNFα of 0.5h was still higher than the control (P<0.05),
and its expressions of 1h, 3h, and 6h were downregulated
obviously, which showed signiﬁcant diﬀerence from the
model level (P<0.05). Baicalin did not apparently aﬀect
the expression of protein caspase3, which was shown in
Figure 4(a).
After the addition of wogonoside (10μg/mL), TLR2 and
TNFα were downregulated apparently. The expression of
TLR2 was much lower than that of the model, even than
the normal level (P<0.05). Accordingly, the expression ofJournal of Biomedicine and Biotechnology 5
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Figure 3: Protection of baicalin, wogonoside, baicalein, and wogonin in PC12 cell with oxygen-glucose deprivation (OGD) (MTT assay).
After24hofcellsincubationin96-wellplatesand2hoxygen-glucosedeprivation,thecompoundswereaddedwiththedosagefrom1mg/mL
to 0.001mg/mL. #P<0.05 versus normal control. ∗P<0.05 versus model. Data were presented as mean ± S.D. from seven independent
experiments.
TNFα was inhibited by wogonoside apparently from 0.5h
after its administration till the timepoint of 6h (P<
0.05). Wogonoside also did not show obvious eﬀect on the
expression of caspase3 (Figure 4(b)).
After baicalein administration, TLR2 was still upregu-
lated signiﬁcantly 0.5h and 1h after the addition of baicalein
(P<0.05), and it decreased down to the normal at 3h
and 6h. Comparing with the model, TNFα was upregulated
at 0.5h and decreased gradually later. Like TLR2, it was
expressed down to the normal at 3h and 6h (Figure 4(c)).
In wogonin group, the two factors decreased apparently.
TLR2 decreased to the normal after 0.5h of the addition of
wogonin(comparingwiththemodel,P<0.05),anditstayed
atalowerlevelduringtheexperimentcourse.Inthe0.5hand
1h time points, TNFα was expressed more than the normal
(P<0.05) but less than the model (P<0.05), and at 3h and
6h, it came close to the normal level like TLR2 expression
(Figure 4(d)).
Similar to baicalin and wogonoside groups, the expres-
sion of caspase3 showed no signiﬁcant change in baicalein
and wogonin groups (Figures 4(c) and 4(d)).
3.4. Assay of Total Antioxidation Competence (T-AOC). Util-
izing the T-AOC kit, we found that the antioxidation
competence of the normal cells was about 2.5U/mg, and
o n eo ft h ec e l l st r e a t e db yo x y g e n - g l u c o s ed e p r i v a t i o nw a s
far below 0.5U/mg. In baicalin group, the detection value
was 1.8U/mL, showing a signiﬁcant diﬀerence no matter
comparing with the normal or comparing with the OGD
model. In wogonoside, baicalein, and wogonin groups, the
values were 1.6, 0.8, and 0.6U/mg, respectively, which all
showed a signiﬁcant diﬀerence comparing with the normal
or the model (Figure 5).
4. Discussions
Baicalin is a glycosylated compound derived from baicalein,
and it has a functional group of D-glucopyranosiduronic
acid on site 7 of baicalein (Figure 1), so that it will exhibit
more biological function. The basic structure of baicalin
consists of benzopyran with three hydroxyl groups at site
5, 6, and 7 and a phenyl group at the other side of the
benzopyran (site 2). Baicalin also has an enol structure on
the benzopyran ring to maintain the conjugation. The two
diﬀerences between baicalin and wogonin lie in methoxyl
grouponcarbon8ofwogoninandhydroxylgrouponcarbon
6 of baicalein. The constitution of three hydroxyl groups
in baicalin may account for more hydrophilic characters.6 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬀect of the four analogs on the protein expressions of TLR2, TNFα, and caspase3 in PC12 cells with oxygen-glucose deprivation
(OGD). The protein level was measured by Western blot. Model means treatment with oxygen-glucose deprivation. 0.5, 1, 3, and 6h mean
the time of reperfusion process after OGD. (a) stands for baicalin eﬀect; (b) stands for wogonoside eﬀect; (c) stands for baicalein eﬀect; (d)
stands for wogonin eﬀect. Baicalin, wogonoside, and wogonin were used in a concentrating of 10μg/mL, and the baicalein was used in a
concentrating of 1μg/mL. ∗P<0.05 versus normal control. #P<0.05 versus model group. Data were presented as mean ± SD from three
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Figure 5: Eﬀect of baicalin and its three analogs on the total
antioxidation competence of the PC12 cells treated with oxygen-
glucose deprivation. Model means treatment with oxygen-glucose
deprivation.Baicalin,wogonoside,andwogoninwereusedinacon-
centrating of 10μg/mL, the baicalein was used in a concentrating of
1μg/mL. ∗∗P<0.01versusnormalcontrol. ##P<0.01versusmodel
group. $$P<0.01versusbaicalinandwogonosidegroups.Datawere
presented as mean ± S.D. from eight independent experiments.
Moreover, wogonoside is a glycosylated form of wogonin
with D-glucopyranosiduronic acid on carbon 7. All four
compounds share similar carbon skeleton with a benzopyran
structure and also a hydroxyl group on carbon 5; baicalein
and baicalin have hydroxyl groups on carbon 6, while wogo-
nin and wogonoside does not have; baicalein and wogonin
have hydroxyl groups on carbon 7, while wogonoside and
baicalin are both glycosylated on the hydroxyl group at
site 7; last, wogonin and wogonoside have methoxyl groups
on carbon 8, but baicalein and baicalin does not have the
functional groups [44, 45].
By the result of cytotoxicity and neuroprotection, D-
glucopyranosiduronic acid on site 7 was important for
reducing cytotoxicity, in which baicalin was less cytotoxic
than baicalein and wogonoside was less cytotoxic than wogo-
nin. Methoxyl group on carbon 8 and hydroxyl group on
carbon 6 were the major factor inﬂuencing the neuropro-
tective eﬀect, by which the EC50 of baicalin and baicalein
was less than that of wogonoside and wogonin (Figure 1 and
Table 1) after they were administered.
In this study, we found that TLR2 was highly expressed
during the oxygen and glucose deprivation (OGD) dam-
age in PC12 cells, which suggested that the receptor was
a c t i v a t e di nt h ed a m a g e dn e u r o n s( Figure 4). TLR2 had
been identiﬁed as a key mediator of immune responses and
inﬂammatory reactions, and it mediated proinﬂammatory
responses through activating of TNFα [46–48]. The receptor
was signiﬁcantly up-regulated comparing with the normal
level, indicating it joined neuron injury induced by OGD.
By the literature of research, TLR2 in the central nerve
system (CNS) is realized as the direct source of the damaging
signal and an important potential therapeutic target [49]. In
our results, the expressions of TLR2 and TNFα decreased
apparently a few hours after we added the compounds.
In the same proﬁle, the expressions of TLR2 and TNFα
with wogonin and wogonoside were more inhibited than
those with baicalin and baicalein. The inhibition of the
expression started from 0.5h after wogonin and wogonoside
administration; however the inhibition of TLR2 and TNFα
expression appeared later at 3h after baicalin and baicalein
administration. Therefore, wogonin and wogonoside were
realized to have preference with TLR2. Combined with their
chemical structures, all the results implied that methoxyl
group on carbon 8 in the structure is the pharmacophore
hypothesis of the eﬀect of TLR2 inhibition, relating to
inﬂammation inhibition.
Conditioning the oversuppression on TLR2 and TNFα
by these analogs, we detected caspase3 to conﬁrm whether
there existed apoptosis with the addition of the analogs.
Comparing with the normal, the expression of caspase3
protein in OGD model indeed increased in some degree,
but showed no statistical diﬀerence. With the administration
of the four analogs, the level caspase3 protein showed no
obvious change, although it showed the tendency to decrease
at 6h time point and near to the normal control (comparing
with the normal or the model, P>0.05). The above results
suggested the injured PC12 cells in OGD model had no
apparent apoptosis, and the four analogs also could not
induce apoptosis in the injured PC12 cells. According to the
literature, baicalin attenuated global cerebral ischemia reper-
fusion injury in gerbils via antioxidative and antiapoptotic
pathways[50],andbaicaleinandwogonincouldboth induce
the apoptosis in human pancreatic cancer cells and HL-60
leukemia cells [51, 52]. Therefore, our results of apoptosis by
these compounds need to be studied further.
Referring to the T-AOC detection, we found that the
total antioxidation capability sequence was baicalin and
wogonoside > baicalein and wogonin, indicating that a
glycosylatedformonsite2ofbaicalinandwogonosideplayed
a key role in overall antioxidation.
Taken together, baicalin and its three analogs presented
comprehensively the protection of neuron cells from OGD
damage and the inhibition of TLR2 expression and TNFα
(the factor in the downstream), suggesting the possibility of
these compounds used in stroke therapy by targeting TLR2,
one of the major mechanisms of the cerebral damage. There
is a structure-activity relationship among them with safety,
eﬃcacy, and speciﬁcity of drug targeting of TLR2. This is
the ﬁrst time to study baicalin and its natural analogs on
molecular targets of TLR2 and TNFα,a sw e l la sT - A O C .A l l
that will have beneﬁt in elucidating and developing them for
the new drugs.
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